The Alzheimers Disease Neuroimaging Initiative(ADNI) is a longitudinal multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimers disease (AD).
- Multi-parametric MRI.
- Amyloid and Tau PET imaging.
- Genetic profiles, and blood and cerebrospinal fluid biomarkers.
Number of subjects / images: 2000 subjects.
Link to dataset / homepage : http://adni.loni.usc.edu/data-samples/access-data/